Alfonso Tafur Shares Series of Events in Celebration for World Thrombosis Day and Hispanic Heritage Month
Alfonso Tafur, Vascular Medicine Fellowship Program Director at University of Chicago, Director of Vascular Medicine Department at NorthShore University, shared on LinkedIn:
”Just one month away!
Thrilled to share a series of events that combine awareness, science, and celebration for World Thrombosis Day and Hispanic Heritage Month:
October 9 – Outside the box: I’ll be stepping onto the stage with Giordano Dance Chicago in Dancing with the Giordano Stars—celebrating flow, movement, and circulation
October 10 – Honored to welcome Dr. Chirinos, who will deliver a lecture on Aortic Aging, bridging imaging science and vascular health.
October 11 – Proud to host a World Thrombosis Day Symposium, bringing together distinguished colleagues and leading experts in thrombosis for a powerful exchange of knowledge.
Lectures will be streamed live. Mark your calendars, join the celebration, and help elevate awareness.
Together, let’s move science, awareness, and community forward.”
Find Alfonso Tafur’s Foundraising Page here.
Stay updated on the latest news on thrombosis field with Hemostasis Today.
-
Oct 19, 2026, 14:16Hyperfibrinolysis as an Underrecognized Cause of Bleeding
-
Oct 19, 2026, 13:36Shobhna Ladva: Aspen Pharma EME Raises Awareness of Blood Clot Risks During Hormonal Transitions
-
Oct 19, 2026, 13:11Giulia Furnari: Connecting With Global Hematology Experts at IACH 2026
-
Oct 19, 2026, 12:46Andrew Choong: Recognizing Thrombosis Before It Becomes Life-Threatening
-
Oct 19, 2026, 11:37Beth Faiman: APSHO Fellows Celebrated for Advancing Hematology and Oncology Practice
-
Oct 19, 2026, 11:26Emanuele Pacini: Myelodysplastic Syndromes Research Featured at JSH Annual Meeting in Kyoto
-
Oct 19, 2026, 10:57Jesmond Dalli: How Erythroblasts Shape Neutrophil Development and Function
-
Oct 19, 2026, 10:41Hisham Fahmi: SCD – Should Gene Editing Begin Before Organ Damage?
-
Oct 19, 2026, 10:33Pallavi Madhiraju: YARTEMLEA Faces Another European Rejection Despite FDA Approval